[publication] Use of Inhaled Epoprostenol in Patients With COVID-19 Receiving Humidified, High-Flow Nasal Oxygen Is Associated With Progressive Respiratory Failure - Andrew P. Michelson, MD

Andrew P. Michelson, MD

Assistant Professor | Director, Critical Care Informatics Research | Faculty Affiliate, Institute for Informatics | Intensivist | Physician Scientist

09.24.2023

Use of Inhaled Epoprostenol in Patients With COVID-19 Receiving Humidified, High-Flow Nasal Oxygen Is Associated With Progressive Respiratory Failure

Check out our latest work looking at the use of inhaled epoprostenol for COVID-19 patients on humidified, high flow nasal cannula.

https://www.sciencedirect.com/science/article/pii/S2949788423000199

informatics| COVID-19| HHFNC| COVID-19